U.S. Food et al., 1996-11-22: FDA approval package for NDA 050742. The approval letter is dated 11/22/96 and approves ivermectin tablets for strongyloidiasis and onchocerciasis; the cover sheet gives 'APPROVAL DATE: 11/22/96' and trade name Mectizan.
We have completed the review of this application, including the submitted draft labeling, and have concluded that adequate information has been presented to demonstrate that the drug product is safe and effective for use as recommended in the enclosed draft labeling.
2 (PDF p.2)
U.S. Food et al., 1996-11-22: FDA approval package for NDA 050742. The approval letter is dated 11/22/96 and approves ivermectin tablets for strongyloidiasis and onchocerciasis; the cover sheet gives 'APPROVAL DATE: 11/22/96' and trade name Mectizan. Record field: cover page reads 'APPLICATION NUMBER: 050742 / TRADE NAME: Mectizan / GENERIC NAME: Ivermectin / SPONSOR: Merck Research Laboratories / APPROVAL DATE: 11/22/96'; letter dated 'NOV 22 1996' (OCR shows 'NOV22 19%'). NDA submitted March 29, 1996 (Type 1 new molecular entity, priority review). Confirmed independently by the openFDA drugsfda record for NDA050742 (submission ORIG/1, status AP, submission_status_date 19961122; marketing status 'Discontinued' for both strengths). NDA 050742 was NOT a 1987 approval. Also filed as IVA-56 (claims C1, F1). Study type: regulatory record.
